Tempest Therapeutics, Inc. Foreign Currency Transaction Gain (Loss), before Tax
Tempest Therapeutics, Inc. (TPST) reported Foreign Currency Transaction Gain (Loss), before Tax of $174.00 thousand for the 3-month period ending 2021-03-31, per its 10-Q filed 2021-05-13.
Discontinued › Income Statement › Other Income
us-gaap:ForeignCurrencyTransactionGainLossBeforeTax · last filed 2021-05-13
- Tempest Therapeutics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2021-03-31 was $174.00K.
- Tempest Therapeutics, Inc. foreign currency transaction gain (loss), before tax for the quarter ending 2020-03-31 was $0.00.
| Period end | Foreign Currency Transaction Gain (Loss), before Tax 3 month |
|---|---|
| 2021-03-31 | $174.00K 10-Q · filed 2021-05-13 |
| 2020-03-31 | $0.00 10-Q · filed 2021-05-13 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aspire Biopharma Holdings, Inc. (ASBP) | United States | $0.012B | -0.60 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| LISATA THERAPEUTICS, INC. (LSTA) | United States | $0.014B | -2.13 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B |